MedChem Europe, Berlin, 13-14 April 2005, will include topics of interest in the pharmaceutical industry and encompasses major target families such as kinases, GPCRs, and proteases
Scientific Update and Select Conferences announce their first joint European conference on medicinal chemistry, which they say will provide the main European forum for cutting edge work within this dynamic field and an unmissable event for those wishing to keep abreast of new developments.
Topics at this conference will include theoretical considerations as well as case histories, interactive workshops, recent developments in the field of kinase and protease inhibitors, the design of ligands for challenging GPCR targets, and nanotechnology.
This multidisciplinary conference focuses on current approaches to the design of molecules with therapeutic indications and is relevant to chemists in both industry and academia.
MedChem Europe will be held at the Messe Berlin in conjunction with the BioFine 2005 exhibition for fine chemicals and drug discovery.
Scientific Update will be hosting two pre-conference half-day seminars: Saqinavir - more than a success story, and Speeding up chemistry: organic synthesis using microwaves.
Speakers will include top scientists from Bayer, Novartis, Amgen, Moscow State University, GlaxoSmithKline, Johnson and Johnson, Lilly, and Schering.
